Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) set up its second overseas regulatory office in Washington, four ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of CARVYKTI to transform outcomes in refractory multiple myeloma ...

Tokyo, Japan and Cambridge, UK, 1 November 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or ...

Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese ...

Japan has had restrictive policies on low-skilled foreign labor. However, recent changes signal a shift toward greater openness. As of October 31, 2023, the number of foreign workers in Japan reached ...

To this end, mortality data was extracted from life tables published by the Ministry of Health, Labor, and Welfare (MHLW), and psychological distress data was taken from the Comprehensive Survey ...

Japan updated its guidelines on THC limits for CBD products, however some industry experts point out gaps. The European Commission has launched an investigation into Italy’s effort to ban trade ...

The therapy received its first global approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) in March 2024, and gained subsequent endorsements by the UK’s Medicines and Healthcare ...